12882_2019_1340_MOESM1_ESM.docx (17.57 kB)
Additional file 1: of Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus SandimmunÂŽ Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants
journal contribution
posted on 2019-05-14, 05:00 authored by Anja Gäckler, Sebastian Dolff, Hana Rohn, Johannes Korth, Benjamin Wilde, Ute Eisenberger, Anna Mitchell, Andreas Kribben, Oliver WitzkeFigure S1. Inclusion and exclusion criteria. (DOCX 27 kb)